Fundamentals: Pharmacology - Drugs in pregnancy and the elderly Flashcards
Seven factors affecting placental drug transfer
- Lipid solubility: increased lipid solubility increases placental transfer (e.g. thiopental)
- Drug ionisation: increased ionisation decreases placental transfer (relative: increased transfer with increasing concentration and lipid solubility)
- Molecular size: cross placenta easily if 250-500MW
- pKa: maternal blood pH is 7.4 and foetal blood pH is 7.3 (basic drugs with pKa >7.4 will undergo ion trapping in foetus)
- Placental transporters: may pump drugs back into maternal circulation (or vice versa)
- Protein binding: drug transfer impeded by maternal protein binding (more important for lipid soluble drugs), foetal proteins also have lower binding affinity than maternal (e.g. sulfonamides, barbiturates, phenytoin, local anaesthetics)
- Placental and foetal metabolism: placenta itself can metabolise drugs to produce either active or inactive metabolites (e.g. prednisolone metabolised to inactive prednisone - can be used in pregnancy without steroid exposure to foetus), 40-60% of umbilical venous blood enters liver (first pass metabolism), some drugs in umbilical artery may be shunted through placenta back to umbilical vein
What % of umbilical venous blood enters the liver?
40-60%
Three characteristics of teratogens
- Results in characteristic set of malformations
- Exerts effects at particular stage of foetal development
- Shows dose-dependent incidence
Describe the five teratogenic risk categories
Category A: possibility of harm remote
Category B: no risk in animal-reproduction studies but no studies in human pregnancy, OR adverse effect in animal-reproduction studies but not confirmed in human pregnancy
Category C: adverse effect in studies in animals, but no studies available in human pregnancy (or no studies available at all)
Category D: evidence of human foetal risk but benefits to pregnant woman may be acceptable (e.g. life-threatening or no alternatives in serious disease)
Category X: evidence of risk in human and animal studies (or in clinical experience), risk outweight benefit
Six examples of drugs that are category A in pregnancy
- Cephalexin
- Chloromycetin ear drops
- Nitrofurantoin
- Metoclopramide
- Sulfasalazine
- Methyldopa
Two examples of drugs that are category B in pregnancy
- Dicloxacillin
- Vancomycin
Eight examples of drugs that are category C in pregnancy
- Oxycodone
- Morphine
- Enoxaparin
- Heparin
- Promethazine
- Metoprolol
- Nifedipine
- Digoxin
Two adverse effects of ACEIs in pregnancy
- Renal damage
- Hypocalvaria
Two antibiotics contraindicated in pregnancy and their effects
- Tetracyclines (contraindicated throughout pregnancy): discolouration and defects of teeth and altered bone growth
- Chloramphenicol (contraindicated in 3rd trimesters): “grey baby syndrome” (cyanosis, hypothermia, CV collapse)
During what trimester of pregnancy are ACEIs contraindicated?
Throughout
Seven recreational drugs contraindicated in pregnancy and their adverse effects
- Amphetamines: abnormal developmental patterns, decreased school performance
- Barbiturates: neonatal dependence with chronic use
- Cocaine: increased risk of spontaneous abortion, placental abruption, premature labour, and neonatal cerebral infarction; abnormal development, decreased school peformance
- Ethanol: foetal alcohol spectrum disorder
- Diazepam: neonatal dependence with chronic use
- Heroin, methadone: neonatal abstinence syndrome with chronic use
- Tobacco smoking: IUGR, prematurity, SIDS, perinatal complications
Four anticonvulsants contraindicated in pregnancy and their adverse effects
- Phenytoin (contraindicated throughout pregnancy): foetal hydantoin syndrome (IUGR, microencephaly, limb defects, congenital heart defects)
- Valproate (contraindicated throughout pregnancy): neural tube defects, cardiac and limb malformations, developmental delay, possibly autism
- Carbamazepine (contraindicated in 1st trimester): neural tube defects
- Topiramate (contraindicated in 1st trimester): oral cleft
Adverse effects of warfarin in pregnancy
1st trimester: hypoplastic nasal bridge, chondrodysplasia punctata
2nd trimester: CNS malformations
3rd trimester: risk of bleeding (discontinue for 1 month before delivery)
Oral hypoglycaemics contraindicated in pregnancy and their adverse effects
Chlorpropamide (sulfonylurea): prolonged symptomatic neonatal hypoglycaemia
Three thyroid medications contraindicated in pregnancy and their adverse effects
- Iodide: congenital goiter, hypothyroidism
- Methylthiouracil: hypothyroidism
- Propylthiouracil: congenital goiter
Adverse effects of isotretinoin in pregnancy
Extremely high risk of CNS, face, ear and other malformations
Adverse effects of lithium in pregnancy
1st trimester: Ebstein’s anomaly (congenital heart defect involving tricuspid valve)
3rd trimester: neonatal toxicity
Adverse effects of corticosteroids in pregnancy
Cleft palate in 1st trimester
Two antidepressants contraindicated in pregnancy and their adverse effects
In 3rd trimester:
1. Tricyclic antidepressants: neonatal withdrawal
2. SSRIs: neonatal abstinence syndrome, persistent pulmonary HTN of newborn
Adverse effects of androgens in pregnancy
Masculinisation of female foetus in 3rd trimester